Alan Stewart Buys 33,923 Shares of Haleon plc (LON:HLN) Stock

Haleon plc (LON:HLN) insider Alan Stewart bought 33,923 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The shares were bought at an average price of GBX 368 ($4.79) per share, with a total value of £124,836.64 ($162,505.39).

Haleon Price Performance

Shares of Haleon stock opened at GBX 363.30 ($4.73) on Friday. The stock has a market capitalization of £32.84 billion, a price-to-earnings ratio of 3,027.50, a P/E/G ratio of 1.49 and a beta of 0.19. The firm’s 50-day moving average price is GBX 383.61 and its two-hundred day moving average price is GBX 355.08. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 54.18. Haleon plc has a 1-year low of GBX 308.37 ($4.01) and a 1-year high of GBX 400.65 ($5.22).

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank lifted their price objective on Haleon from GBX 410 ($5.34) to GBX 447 ($5.82) and gave the company a “buy” rating in a report on Monday, August 5th.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.